MarissaBWilckMD
Infectious Disease • Philadelphia, PATransplant/Immunocompromised States, Microbiology
Assistant Professor, Medicine, Perelman School of Medicine
Dr. Wilck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St.
3 Silverstein Bldg., Suite D
Philadelphia, PA 19104Phone+1 215-662-6932Fax+1 617-662-7899
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2004 - 2007
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2000 - 2004
Yale-New Haven Medical CenterFellowship, Medical Microbiology, 1999 - 2000
University of Cape Town Faculty of MedicineClass of 1996
Certifications & Licensure
PA State Medical License 2010 - 2024
MA State Medical License 2005 - 2010
DC State Medical License 2003 - 2004
DE State Medical License 2002 - 2003
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen ...Alvino Maestri, Su Eun Park, Fiona Fernandes, Zhongyi Lucy Li, Yae-Jean Kim
Human Vaccines & Immunotherapeutics. 2024-12-31 - A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hi...Andrea Guerra, Claudio Costantino, Federico Martinon-Torres, Soeren Westerholt, Courtney Lambeth
Human Vaccines & Immunotherapeutics. 2024-12-31 - 4 citationsA Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vacci...Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, Juan Diego Velez, Per Ljungman
Clinical Infectious Diseases. 2023-10-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
